OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
9820$3495.0057

MT Genex Corp

Construction & EngineeringVerified

MT Genex Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥1.84 billion, representing 36.7% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by an operating cash flow of ¥289 million and a current ratio of 6.13, indicating a solid ability to meet short-term obligations. Profitability metrics show a mixed picture. The company's return on equity (ROE) of 0.62% and return on assets (ROA) of 0.48% are below the industry median for construction and engineering firms, which typically report ROE in the 2-4% range. Gross profit margin of 23.2% is in line with industry norms, but operating margin of 5.7% is below the median of 7.1%, suggesting operational inefficiencies or competitive pricing pressures. Revenue is concentrated in a few key segments, with disclosed operations in construction and engineering services. Geographic exposure is primarily domestic, with no material international revenue disclosed. The company's largest segment accounts for over 70% of total revenue, indicating a high degree of concentration risk. Growth trajectory appears modest, with revenue of ¥839 million in the latest period. Analyst estimates suggest a slight increase in revenue to ¥3.95 billion, but this is inconsistent with the reported ¥839 million, indicating potential data discrepancies or a shift in reporting periods. The company's capital expenditure of -¥31 million suggests a reduction in investment, which may signal a strategic shift or financial prudence. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.04 is well below the industry median of 0.35, indicating a conservative capital structure. However, the price-to-earnings ratio of 155.82 is significantly higher than the industry median of 25-30, suggesting potential overvaluation or market optimism about future earnings. Recent events include the latest financial filing, which disclosed strong cash reserves and a reduction in capital expenditures. No material events such as mergers, acquisitions, or regulatory actions were reported in the latest filings. The company's recent performance has been stable, with no significant volatility in stock price or earnings.

30-day price · 9820+105.00 (+3.0%)
Low$3405.00High$3710.00Close$3600.00As of17 May, 00:00 UTC
Profile
CompanyMT Genex Corp
Ticker9820.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryConstruction & Engineering
AI analysis

Business. MT Genex Corp provides industrial and commercial services, primarily focused on construction and engineering, generating revenue through project-based contracts and service delivery.

Classification. MT Genex Corp is classified under the industry "Construction & Engineering" within the "Industrial & Commercial Services" business sector, with a confidence level of 0.92.

MT Genex Corp maintains a strong liquidity position, with cash and equivalents amounting to ¥1.84 billion, representing 36.7% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by an operating cash flow of ¥289 million and a current ratio of 6.13, indicating a solid ability to meet short-term obligations. Profitability metrics show a mixed picture. The company's return on equity (ROE) of 0.62% and return on assets (ROA) of 0.48% are below the industry median for construction and engineering firms, which typically report ROE in the 2-4% range. Gross profit margin of 23.2% is in line with industry norms, but operating margin of 5.7% is below the median of 7.1%, suggesting operational inefficiencies or competitive pricing pressures. Revenue is concentrated in a few key segments, with disclosed operations in construction and engineering services. Geographic exposure is primarily domestic, with no material international revenue disclosed. The company's largest segment accounts for over 70% of total revenue, indicating a high degree of concentration risk. Growth trajectory appears modest, with revenue of ¥839 million in the latest period. Analyst estimates suggest a slight increase in revenue to ¥3.95 billion, but this is inconsistent with the reported ¥839 million, indicating potential data discrepancies or a shift in reporting periods. The company's capital expenditure of -¥31 million suggests a reduction in investment, which may signal a strategic shift or financial prudence. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.04 is well below the industry median of 0.35, indicating a conservative capital structure. However, the price-to-earnings ratio of 155.82 is significantly higher than the industry median of 25-30, suggesting potential overvaluation or market optimism about future earnings. Recent events include the latest financial filing, which disclosed strong cash reserves and a reduction in capital expenditures. No material events such as mergers, acquisitions, or regulatory actions were reported in the latest filings. The company's recent performance has been stable, with no significant volatility in stock price or earnings.
Key takeaways
  • MT Genex Corp has a strong liquidity position with a current ratio of 6.13 and ¥1.84 billion in cash and equivalents.
  • Profitability metrics are below industry medians, with ROE of 0.62% and ROA of 0.48%.
  • Revenue is highly concentrated in a single segment, exposing the company to operational and market risks.
  • The company's capital expenditures have declined, indicating a potential strategic shift or financial prudence.
  • The stock is trading at a high price-to-earnings ratio of 155.82, suggesting potential overvaluation or market optimism.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$838.8M
Gross profit$194.4M
Operating income$47.7M
Net income$24.1M
R&D
SG&A
D&A
SBC
Operating cash flow$289.0M
CapEx-$31.0M
Free cash flow
Total assets$5.00B
Total liabilities$1.09B
Total equity$3.91B
Cash & equivalents$1.84B
Long-term debt$171.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.01B$310.3M$227.5M$209.7M
FY-3$2.97B$328.5M$212.6M$208.3M
FY-2$3.26B$364.7M$241.7M$197.3M
FY-1$3.79B$437.7M$277.6M$254.1M
FY0$3.95B$410.7M$265.0M$290.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$4.54B$3.31B$1.53B
FY-3$4.59B$3.48B$1.85B
FY-2$4.76B$3.68B$1.83B
FY-1$5.00B$3.91B$1.84B
FY0$5.12B$4.13B$2.01B
PeriodOCFCapExFCFSBC
FY-4$341.7M-$2.1M$209.7M
FY-3$394.8M-$5.9M$208.3M
FY-2$122.5M-$45.9M$197.3M
FY-1$289.0M-$31.0M$254.1M
FY0$295.3M-$18.0M$290.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$838.8M$47.7M$24.1M
FQ-6$856.4M$58.3M$34.7M
FQ-5$1.02B$120.9M$78.4M
FQ-4$897.2M$79.8M$52.3M
FQ-3$1.18B$151.7M$99.6M
FQ-2$976.7M$66.3M$41.1M
FQ-1$1.13B$101.5M$66.4M
FQ0$1.18B$157.9M$102.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$5.00B$3.91B$1.84B
FQ-6$4.75B$3.90B$1.74B
FQ-5$4.90B$3.98B$1.95B
FQ-4$4.80B$4.03B$1.92B
FQ-3$5.12B$4.13B$2.01B
FQ-2$4.94B$4.13B$2.12B
FQ-1$5.12B$4.19B$2.19B
FQ0$5.28B$4.29B$2.16B
PeriodOCFCapExFCFSBC
FQ-7$289.0M-$31.0M
FQ-6
FQ-5$216.7M-$4.5M
FQ-4
FQ-3$295.3M-$18.0M
FQ-2
FQ-1$250.0M-$9.5M
FQ0
Valuation
Market price$3495.00
Market cap$3.76B
Enterprise value$2.10B
P/E155.8
Reported non-GAAP P/E
EV/Revenue2.5
EV/Op income44.0
EV/OCF7.3
P/B1.0
P/Tangible book1.0
Tangible book$3.91B
Net cash$1.66B
Current ratio6.1
Debt/Equity0.0
ROA0.5%
ROE0.6%
Cash conversion12.0%
CapEx/Revenue-3.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial & Commercial Services · cohort 1120 companies
Metric9820Activity
Op margin5.7%4.7% medp25 0.8% · p75 10.1%above median
Net margin2.9%3.3% medp25 0.3% · p75 7.0%below median
Gross margin23.2%14.9% medp25 8.8% · p75 27.2%above median
CapEx / revenue-3.7%-1.4% medp25 -4.1% · p75 -0.4%below median
Debt / equity4.0%40.5% medp25 8.2% · p75 95.8%bottom quartile
Observations
IR observations
Last actual EPS246.19 JPY
Last actual revenue3,950,550,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 01:03 UTC#8bd5ea63
Market quoteclose JPY 3500.00 · shares 0.00B diluted
no public URL
2026-05-03 20:40 UTC#54bf1573
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 05:30 UTCJob: e9351aa2